好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Effect of Adjunctive Rufinamide in Pediatric Patients With Inadequately Controlled Lennox-Gastaut Syndrome (LGS): Interim Pharmacokinetic and Safety Results From Study 303
Epilepsy/Clinical Neurophysiology (EEG)
(-)
242
Authors/Disclosures
Jose A. Ferreira, MD (Pediatric Epilepsy and Neurology Specialists)
PRESENTER
Dr. Ferreira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex Biosciences. Dr. Ferreira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. The institution of Dr. Ferreira has received research support from SK Bioscience. The institution of Dr. Ferreira has received research support from Longboard/Lumbeck Pharma. The institution of Dr. Ferreira has received research support from Emalex Biosciences. The institution of Dr. Ferreira has received research support from Eizai Pharmaceuticals. The institution of Dr. Ferreira has received research support from Biohaven Pharmaceuticals. The institution of Dr. Ferreira has received research support from Amgen Pharmaceuticals.
No disclosure on file
Shannon W. Mendes, PhD (Supernus Pharmaceuticals, Inc.) No disclosure on file
Betsy N. Williams, PhD Dr. Williams has received personal compensation for serving as an employee of IQVIA.
No disclosure on file
Edgar Schuck No disclosure on file
Dinesh Kumar Dinesh Kumar has received personal compensation for serving as an employee of Eisai Inc.
Francesco Bibbiani, MD (Eisai) Dr. Bibbiani has nothing to disclose.
Peter A. Calabresi, MD, FAAN (Johns Hopkins University) Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.